Binah Capital Group Inc. (BCG) Stock Price

2.40 ▼ -0.01 (-0.41%)
Open: 2.456 Vol: 11.1K Day's range: 2.40 - 2.56 Jan 16, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
BCG Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 2.49▼ 2.49▼ 2.49▼ 2.47▼ 2.50▼
MA10 2.55▼ 2.55▼ 2.55▼ 2.57▼ 2.38▲
MA20 2.62▼ 2.61▼ 2.61▼ 2.51▼ 2.07▲
MA50 2.68▼ 2.76▼ 2.63▼ 2.29▲ 2.10▲
MA100 2.83▼ 2.57▼ 2.58▼ 2.04▲ N/A    
MA200 2.66▼ 2.51▼ 2.26▲ 2.09▲ N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD -0.020▼ -0.021▼ -0.027▼ -0.036▼ 0.080▲
RSI 26.414▼ 32.837▼ 36.471▼ 48.152▼ 53.144▲
STOCH 5.324▼ 5.324▼ 5.211▼ 25.163     51.279    
WILL %R -100.000▼ -100.000▼ -100.000▼ -78.341▼ -50.000    
CCI -140.519▼ -142.342▼ -139.871▼ -79.604     62.362    
Latest Filters Detected On BCG
CDL $BCG Matching Low Candlestick Pattern Detected Set Alert
Binah Capital Group Inc. News
ImmunityBio Advances Regulatory Discussions with FDA on Potential Resubmission Path for ANKTIVA® in BCG-Unresponsive Papillary Bladder Cancer
Tuesday, January 20, 2026 04:05 AM
Following discussions with the U.S. FDA, the Agency recommended that the Company submit additional information for its evaluation of this information to potentially support a resubmission of the sBLA ...
ImmunityBio Advances First-Line BCG Naive NMIBC Program with Enrollment Exceeding Expectations and Positive Interim Analysis for ANKTIVA® Plus BCG
Friday, January 16, 2026 04:10 AM
ImmunityBio, Inc. (NASDAQ: IBRX) today announced an update on the status of enrollment in its randomized registrational trial in BCG-naïve non-muscle-invasive bladder cancer (NMIBC), QUILT-2.005.
HC Wainwright asserts buy stance as ImmunityBio, Inc. (IBRX) achieves positive results on bladder cancer treatment
Wednesday, January 14, 2026 11:13 AM
ImmunityBio, Inc. (NASDAQ:IBRX) is one of the best penny stocks to buy for 2026. On December 16, ImmunityBio, Inc. (NASDAQ:IBRX) delivered positive clinical trial results for its ANKTIVA plus BCG ...
BCG historical stock data
date open high low close volume
16/01/26 2.456 2.56 2.40 2.40 11,100
15/01/26 2.57 2.57 2.32 2.41 5,596
14/01/26 2.37 2.58 2.37 2.58 8,300
13/01/26 2.62 2.68 2.335 2.35 25,100
12/01/26 2.60 2.95 2.60 2.62 24,900
09/01/26 2.60 2.68 2.60 2.68 11,900
08/01/26 2.72 2.74 2.53 2.63 37,800
07/01/26 2.82 2.82 2.60 2.63 9,600
06/01/26 2.69 2.935 2.56 2.68 32,400
05/01/26 2.64 2.90 2.64 2.69 15,200
Quote Details
52wk Low:1.36
52wk High:5.81
Vol:11.1K
Avg Vol(3m):13.3M
1Y Chng:+18.23%
1M Chng:+3.00%
Add to Watch List
More Information
Index US Composite
Market Cap. 39.85M